Aminobenzoic Acid
CAS 150-13-0
Aminobenzoic Acid (CAS 150-13-0) is a pharmaceutical compound with 5 bioactivity targets and 715 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 95962.05636363635 nM | 55 | - |
| - | AC50 | 27170.354545454546 nM | 33 | - |
| - | Potency | 22180.27 nM | 10 | - |
| - | MIC | 216.66666666666666 ug.mL-1 | 6 | - |
| - | IC50 | 10946.955 nM | 3 | - |
| - | Kd | 22810 nM | 2 | - |
| - | MIC | 800000 nM | 1 | - |
| Carbonic anhydrase 2 Enzyme |
Ki | 5.09 | - | Homo sapiens |
| Carbonic anhydrase 1 Enzyme |
Ki | 5.08 | - | Homo sapiens |
| Acetylcholinesterase Enzyme |
IC50 | 7.45 | - | Rattus norvegicus |
| Polyphenol oxidase 2 Enzyme |
IC50 | 5.42 | - | Agaricus bisporus |
| Dihydropteroate synthase Enzyme |
Kd | 5.25 | - | Bacillus anthracis |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Appendicolith | 40 | 181.486 | 10074458 |
| Somnolence | 91 | 172.244 | 10041349 |
| Blood phosphorus increased | 39 | 166.299 | 10050196 |
| Appendicitis | 40 | 141.561 | 10003011 |
| Pneumonia aspiration | 53 | 141.057 | 10035669 |
| Ventricular fibrillation | 40 | 126.165 | 10047290 |
| Coma | 53 | 121.091 | 10010071 |
| Blood uric acid increased | 32 | 119.296 | 10005861 |
| Gastrooesophageal reflux disease | 55 | 118.342 | 10017885 |
| Cardiogenic shock | 40 | 116.556 | 10007625 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| AMINOBENZOIC ACID | 74 | SU | MTHSPL |
| Aminobenzoic Acid | 74 | SU | MTHSPL |
| aminobenzoic acid | 74 | SY | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Aminobenzoic Acid used for in pharmaceutical contexts?
Aminobenzoic Acid (CAS 150-13-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Aminobenzoic Acid?
Aminobenzoic Acid has 715 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Appendicolith, Somnolence, Blood phosphorus increased, Appendicitis, Pneumonia aspiration. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Aminobenzoic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for PABA with EU status "restricted".
What clinical phase is Aminobenzoic Acid in?
No phase 1-4 clinical development badge is rendered for Aminobenzoic Acid because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Aminobenzoic Acid?
Aminobenzoic Acid has 12 bioactivity rows in this page query. Rendered target entries include Carbonic anhydrase 2, Carbonic anhydrase 1, Acetylcholinesterase, Polyphenol oxidase 2, Dihydropteroate synthase.